Focus

diabetes

LATEST

Ozempic Users Face Double Risk of Rare Vision Loss, Nordic Studies Find

Ozempic Users Face Double Risk of Rare Vision Loss, Nordic Studies Find
|

Fat Molecule Holds Clues for Treating Diabetic Heart Disease

Fat Molecule Holds Clues for Treating Diabetic Heart Disease
|

Diabetes Drug May Help Fight Lung Cancer in Overweight Patients: Study

Diabetes Drug May Help Fight Lung Cancer in Overweight Patients: Study
|

Early Warning Signs and Minimally Invasive Surgical Approaches in Pancreatic Cancer

Early Warning Signs and Minimally Invasive Surgical Approaches in Pancreatic Cancer
|

Allulose Sugar Alternative May Help With Weight Loss and Blood Sugar Control

Allulose Sugar Alternative May Help With Weight Loss and Blood Sugar Control
|

Customized Vitamin D Supplementation Can Improve Cardiovascular Health

Customized Vitamin D Supplementation Can Improve Cardiovascular Health
|

Why Raspberries Are the New Heart-Healthy Superfruit

Why Raspberries Are the New Heart-Healthy Superfruit
|

A Superfood for Heart, Blood Sugar, and Skin

A Superfood for Heart, Blood Sugar, and Skin
|

Iron Intake From Red Meat Links to Type 2 Diabetes Risk

Iron Intake From Red Meat Links to Type 2 Diabetes Risk
|

Study Links Low Magnesium to DNA Damage and Chronic Disease Risk

Study Links Low Magnesium to DNA Damage and Chronic Disease Risk
|

AI-Enhanced CT Scans May Detect Diabetes During Routine Exams

AI-Enhanced CT Scans May Detect Diabetes During Routine Exams
|

Managing Distress Improves Life, Health for People With Type 1 Diabetes

Managing Distress Improves Life, Health for People With Type 1 Diabetes
|

Hibiscus’ Therapeutic Potential in Type 1 Diabetes and Healthy Adults–Study

Hibiscus’ Therapeutic Potential in Type 1 Diabetes and Healthy Adults–Study
|

Intermittent Fasting Outperforms Diabetes Drugs in New Study

Intermittent Fasting Outperforms Diabetes Drugs in New Study
|

Herbal Remedy Lowers Diabetes Risk by 41 Percent, Faces Challenges for US Approval

Herbal Remedy Lowers Diabetes Risk by 41 Percent, Faces Challenges for US Approval
|